Delivery Order SPE2DB22D1106-SPE2DB25FEBL2
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Abiraterone Acetate 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,102.54 and a completion date of July 9, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor and this award is associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Abiraterone Acetate 500 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,334.05 and a period of performance through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $33,613.26, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price agreement with a performance period through July 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,016.18, is a delivery order for the supply of Abiraterone Acetate 500 mg tablets. It is a firm fixed-price contract with a performance period ending on May 14, 2025. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abiraterone Acetate 500 mg tablets. The $13,720.67 firm fixed-price contract has a completion date of February 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of abiraterone acetate 250 mg tablets. The contract, valued at $13,348.20, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,747.20 firm fixed-price contract is for the delivery of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.50 Firm Fixed Price Delivery Order is for the supply of 4566412806 - ABIRATERONE ACETATE 500 MG TAB 60S, with an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEBL2Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,074.84, is a Firm Fixed Price Delivery Order to provide Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of March 5, 2025. This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/4/25 |